about
Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-AnalysisAssessment of treatment response in tuberculosisHigh frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisUtility of Second-Generation Line Probe Assay (Hain MTBDRplus) Directly on 2-Month Sputum Specimens for Monitoring Tuberculosis Treatment Response.Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes.HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.Immune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report.Screening for asymptomatic lymphogranuloma venereum co-infection in men who have sex with men newly diagnosed with HIV, hepatitis C or syphilis.Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV.Understanding and intervening in HIV-associated tuberculosis.Switching safely: pharmacokinetics, efficacy and safety of switching efavirenz to maraviroc twice daily in patients on suppressive antiretroviral therapy.Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir.Syphilis the great pretender: when is cancer not cancer?Primary central nervous system lymphoma presenting as multiple space-occupying lesions in advanced human immunodeficiency virus infectionUnusual complication and successful high-dose chemotherapy treatment of advanced Burkitt’s lymphoma in an adult HIV-positive patientPancreatic insufficiency in patients with HIV infection: role of didanosine questionedA Comparative Analysis of Risk Factors Associated With Renal Impairment and Highly Active Antiretroviral TherapyGlobal access of rifabutin for the treatment of tuberculosis - why should we prioritize this?
P50
Q26781111-4A8C4ECE-DFE3-4783-AD35-80AC8FE720FBQ28384421-1A0E5F10-4BD5-4504-A5D5-70E58C7CEA36Q28546682-CFF53472-09F8-49DA-8132-A77B0FA4CE9DQ33603890-37EE06CE-FF16-48CB-B427-411B88A2636FQ33621748-72F76BEF-F314-40A4-802F-F7ADB24A9432Q33665347-297B7415-D9FF-442D-A3D1-AF9906760D2CQ37287701-FE052C3E-E2BD-4EAF-AB0B-380D79646830Q37328362-8377D97F-6DB2-4A69-8408-93F9C2CB31C9Q37839970-00C583AE-1FB5-4F09-848B-1275586269A9Q38406461-0570E3AE-240A-4B92-911C-3DAB7D1A8B3AQ38658476-A0003B32-3880-484A-B933-7AA95F398C2EQ39580877-F4FEF4F3-1900-433E-8C93-83A264D46A6BQ41932850-4CA09CA6-4DEA-404E-BCE9-790CFB6AF483Q45002356-D0AC1900-DB61-47E2-BC0E-498DC1016A59Q52362375-DA27AADE-914B-40F5-A4AA-532D3F64B391Q60364167-0A3C132E-82ED-4AB9-8964-A92AD771187EQ60364169-F918342D-522C-4722-804B-DA29D6691727Q60364175-13C1B240-D151-4EEE-91F8-C506724EBDCFQ60364176-76F6F52C-F4F0-4E48-A524-12A897315526Q91984625-B833DBDF-04EB-48A7-9116-CE89908BC333
P50
description
researcher ORCID ID = 0000-0002-7830-1394
@en
wetenschapper
@nl
name
Neesha Rockwood
@ast
Neesha Rockwood
@en
Neesha Rockwood
@es
Neesha Rockwood
@nl
type
label
Neesha Rockwood
@ast
Neesha Rockwood
@en
Neesha Rockwood
@es
Neesha Rockwood
@nl
prefLabel
Neesha Rockwood
@ast
Neesha Rockwood
@en
Neesha Rockwood
@es
Neesha Rockwood
@nl
P106
P1153
47661753100
P21
P31
P496
0000-0002-7830-1394